Literature DB >> 33539340

ATF3 downmodulates its new targets IFI6 and IFI27 to suppress the growth and migration of tongue squamous cell carcinoma cells.

Lin Xu1,2,3,4, Tingjian Zu1,5, Tao Li1,2, Min Li4, Jun Mi1, Fuxiang Bai1, Guanyi Liu1, Jie Wen1, Hui Li6, Cord Brakebusch7, Xuxia Wang2, Xunwei Wu1.   

Abstract

Activating transcription factor 3 (ATF3) is a key transcription factor involved in regulating cellular stress responses, with different expression levels and functions in different tissues. ATF3 has also been shown to play crucial roles in regulating tumor development and progression, however its potential role in oral squamous cell carcinomas has not been fully explored. In this study, we examined biopsies of tongue squamous cell carcinomas (TSCCs) and found that the nuclear expression level of ATF3 correlated negatively with the differentiation status of TSCCs, which was validated by analysis of the ATGC database. By using gain- or loss- of function analyses of ATF3 in four different TSCC cell lines, we demonstrated that ATF3 negatively regulates the growth and migration of human TSCC cells in vitro. RNA-seq analysis identified two new downstream targets of ATF3, interferon alpha inducible proteins 6 (IFI6) and 27 (IFI27), which were upregulated in ATF3-deleted cells and were downregulated in ATF3-overexpressing cells. Chromatin immunoprecipitation assays showed that ATF3 binds the promoter regions of the IFI6 and IFI27 genes. Both IFI6 and IFI27 were highly expressed in TSCC biopsies and knockdown of either IFI6 or IFI27 in TSCC cells blocked the cell growth and migration induced by the deletion of ATF3. Conversely, overexpression of either IFI6 or IFI27 counteracted the inhibition of TSCC cell growth and migration induced by the overexpression of ATF3. Finally, an in vivo study in mice confirmed those in vitro findings. Our study suggests that ATF3 plays an anti-tumor function in TSCCs through the negative regulation of its downstream targets, IFI6 and IFI27.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33539340      PMCID: PMC7888615          DOI: 10.1371/journal.pgen.1009283

Source DB:  PubMed          Journal:  PLoS Genet        ISSN: 1553-7390            Impact factor:   5.917


  62 in total

1.  Circ_0001742 promotes tongue squamous cell carcinoma progression via miR-431-5p/ATF3 axis.

Authors:  Y-T Hu; X-X Li; L-W Zeng
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-12       Impact factor: 3.507

2.  G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell.

Authors:  Eiji Tahara; Hidetoshi Tahara; Masamoto Kanno; Kazuhito Naka; Yayoi Takeda; Takeshi Matsuzaki; Ryuta Yamazaki; Hiroto Ishihara; Wataru Yasui; J Carl Barrett; Toshinori Ide; Eiichi Tahara
Journal:  Cancer Immunol Immunother       Date:  2005-02-01       Impact factor: 6.968

3.  Epidermal hyperplasia and oral carcinoma in mice overexpressing the transcription factor ATF3 in basal epithelial cells.

Authors:  Aijin Wang; Stacey Arantes; Claudio Conti; Mark McArthur; C Marcelo Aldaz; Michael C MacLeod
Journal:  Mol Carcinog       Date:  2007-06       Impact factor: 4.784

Review 4.  ATF3 transcription factor and its emerging roles in immunity and cancer.

Authors:  Matthew R Thompson; Dakang Xu; Bryan R G Williams
Journal:  J Mol Med (Berl)       Date:  2009-08-25       Impact factor: 4.599

5.  Phenformin Promotes Keratinocyte Differentiation via the Calcineurin/NFAT Pathway.

Authors:  Qian Zhou; Sun Hye Kim; Rolando Pérez-Lorenzo; Chang Liu; Man Huang; Gian Paolo Dotto; Bin Zheng; Xunwei Wu
Journal:  J Invest Dermatol       Date:  2020-06-30       Impact factor: 8.551

6.  The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis.

Authors:  Aijin Wang; Stacey Arantes; Leqin Yan; Kaoru Kiguchi; Mark J McArthur; Aysegul Sahin; Howard D Thames; C Marcelo Aldaz; Michael C Macleod
Journal:  BMC Cancer       Date:  2008-09-22       Impact factor: 4.430

7.  Prediction of biomarkers of oral squamous cell carcinoma using microarray technology.

Authors:  Guang Li; Xian Li; Meng Yang; Lvzi Xu; Shixiong Deng; Longke Ran
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

8.  ATF3 and JDP2 deficiency in cancer associated fibroblasts promotes tumor growth via SDF-1 transcription.

Authors:  Shimrit Avraham; Ben Korin; Sharon Aviram; Dvir Shechter; Yuval Shaked; Ami Aronheim
Journal:  Oncogene       Date:  2019-01-22       Impact factor: 9.867

9.  miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT.

Authors:  Nianli Liu; Chaohui Zuo; Xiaohong Wang; Tianran Chen; Darong Yang; Jing Wang; Haizhen Zhu
Journal:  Oncotarget       Date:  2014-07-15

10.  ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression.

Authors:  Cong Chen; Chao Ge; Zheng Liu; Liangyu Li; Fangyu Zhao; Hua Tian; Taoyang Chen; Hong Li; Ming Yao; Jinjun Li
Journal:  J Exp Clin Cancer Res       Date:  2018-10-30
View more
  5 in total

1.  An IFI6-based hydrogel promotes the healing of radiation-induced skin injury through regulation of the HSF1 activity.

Authors:  Jie Hao; Mengyi Sun; Dong Li; Tao Zhang; Jianjun Li; Daijun Zhou
Journal:  J Nanobiotechnology       Date:  2022-06-18       Impact factor: 9.429

2.  Detection of infiltrating fibroblasts by single-cell transcriptomics in human kidney allografts.

Authors:  Hemant Suryawanshi; Hua Yang; Michelle Lubetzky; Pavel Morozov; Mila Lagman; Gaurav Thareja; Alicia Alonso; Carol Li; Catherine Snopkowski; Aziz Belkadi; Franco B Mueller; John R Lee; Darshana M Dadhania; Steven P Salvatore; Surya V Seshan; Vijay K Sharma; Karsten Suhre; Manikkam Suthanthiran; Thomas Tuschl; Thangamani Muthukumar
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

3.  Anti-Tumoral Effect of Chemerin on Ovarian Cancer Cell Lines Mediated by Activation of Interferon Alpha Response.

Authors:  Meike Schmitt; Johanna Gallistl; Susanne Schüler-Toprak; Jürgen Fritsch; Christa Buechler; Olaf Ortmann; Oliver Treeck
Journal:  Cancers (Basel)       Date:  2022-08-25       Impact factor: 6.575

4.  Single-cell transcriptomic profiling for inferring tumor origin and mechanisms of therapeutic resistance.

Authors:  Michael S Lawrence; Daniel L Faden; Maoxuan Lin; Moshe Sade-Feldman; Lori Wirth
Journal:  NPJ Precis Oncol       Date:  2022-10-10

5.  Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis.

Authors:  Jake J Reske; Mike R Wilson; Jeanne Holladay; Rebecca A Siwicki; Hilary Skalski; Shannon Harkins; Marie Adams; John I Risinger; Galen Hostetter; Ken Lin; Ronald L Chandler
Journal:  PLoS Genet       Date:  2021-12-23       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.